Home/Filings/4/0001209191-21-015503
4//SEC Filing

Butt Tausif 4

Accession 0001209191-21-015503

CIK 0001340652other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 9:00 PM ET

Size

5.6 KB

Accession

0001209191-21-015503

Insider Transaction Report

Form 4
Period: 2021-02-25
Butt Tausif
EVP, Chief Operating Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-02-25+87,00087,000 total
    Exercise: $65.87Exp: 2031-02-25Common Stock (87,000 underlying)
Footnotes (2)
  • [F1]The option was granted on February 25, 2021, and 25% of the total number of shares of common stock subject to the option vests on February 23, 2022, and 1/48th of the total number of shares of common stock subject to the option vests monthly thereafter, subject to the Reporting Person's continued service to the Company on each such vesting date.
  • [F2]Not applicable.

Issuer

ChemoCentryx, Inc.

CIK 0001340652

Entity typeother

Related Parties

1
  • filerCIK 0001845266

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 9:00 PM ET
Size
5.6 KB